Skip to search formSkip to main contentSkip to account menu

HBW 023

Known as: HBW-023 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
&NA; The aim of this work has been to assess the effect of diet density [control (CON) or 15% diluted (DIL)] and growth curve… 
1998
1998
ObjectiveTo define an optimal dose of hirudin that would improve early coronary artery Thrombolysis in Myocardial Infarction… 
Highly Cited
1995
Highly Cited
1995
Heparin‐induced thrombocytopenia is a rare but severe complication of heparin therapy that can result in severe venous or… 
1995
1995
To evaluate the efficacy and safety of hirudin, a direct thrombin inhibitor, in patients with acute myocardial infarction, a dose… 
Highly Cited
1994
Highly Cited
1994
Summary Background: Recombinant hirudin, a pure, specific antithrombin could be more effective than heparin in the treatment of… 
Highly Cited
1994
Highly Cited
1994
The first experience with hirudin as an alternative anticoagulant for heparin in hemodialysis is reported. Recombinant hirudin… 
Highly Cited
1993
Highly Cited
1993
Summary Recombinant Hirudin (rH) is an anticoagulant agent with a specific antithrombin activity independent of antithrombin III… 
1993
1993
Recombinant hirudin and a shortened synthetic analogue, with the amino acid sequence of D-Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe…